SMS Pharmaceuticals Limited manufactures and sells active pharmaceutical ingredients (APIs) and its intermediates in India and internationally. It offers anti-retroviral, anti-inflammatory, anti-viral, anti-diabetic, anti-fungal, anti-epileptic, anti-migraine, anti-coagulant, anti-psychotic, anti-aginal, and anti-ulcer products. It is also involved in contract research activities on peptides. The company exports its products to approximately 75 countries. SMS Pharmaceuticals Limited was incorporated in 1987 and is headquartered in Hyderabad, India.
| Current Price | ₹363.95 |
|---|---|
| Market Cap | ₹3,408 Cr |
| Sector | Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals |
| Sub-Industry | Pharmaceuticals > Medicinal Chemicals and Botanical Products |
| P/E Ratio | 32.6 |
| Return on Equity | 14.31% |
| 52-Week Range | ₹207.70 – ₹447.80 |
| Beta (1Y) | 0.99 |
| Dividend Yield | 0.11% |
1. Pharmaceutical Products Including Ingredients and Intermediaries-100%
SMS Pharmaceuticals Ltd. is trading at ₹363.95, with a market capitalisation of ₹3,408 Cr.
SMS Pharmaceuticals Ltd. operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals space (Pharmaceuticals > Medicinal Chemicals and Botanical Products).
SMS Pharmaceuticals Ltd. has a P/E of 32.6 and a return on equity of 14.31%.